Cargando…

Mitochondrial Pharmacology of Dimebon (Latrepirdine) Calls for a New Look at its Possible Therapeutic Potential in Alzheimer’s Disease

Dimebon (latrepirdine), an old antihistaminic drug, showed divergent results in two large clinical trials in Alzheimer disease (AD), which according to our review might be related to the specific pharmacological properties of the drug and the different patient populations included in both studies. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckert, Schamim H, Gaca, Janett, Kolesova, Nathalie, Friedland, Kristina, Eckert, Gunter P, Muller, Walter E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065284/ https://www.ncbi.nlm.nih.gov/pubmed/30090660 http://dx.doi.org/10.14336/AD.2017.1014

Ejemplares similares

Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo
por: Steele, John W, et al.
Publicado: (2009)

Differences in bioavailability and cognitive-enhancing activity exerted by different crystal polymorphs of latrepirdine (Dimebon(®))
por: Gorin, Boris I., et al.
Publicado: (2023)

A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice
por: Chaprov, Kirill, et al.
Publicado: (2021)

Design, Synthesis, Molecular Docking Study and Biological Evaluation of Novel γ-Carboline Derivatives of Latrepirdine (Dimebon) as Potent Anticancer Agents
por: Voggu, Ramakrishna, et al.
Publicado: (2023)

Dimebon disappointment
por: Jones, Roy W
Publicado: (2010)

Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease
por: Wang, Jun, et al.
Publicado: (2011)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Evaluation of Dimebon in cellular model of Huntington's disease
por: Wu, Jun, et al.
Publicado: (2008)

Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases
por: Bharadwaj, P R, et al.
Publicado: (2013)

MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer’s disease
por: Pohland, Maximilian, et al.
Publicado: (2018)

Dimebon Slows Progression of Proteinopathy in γ-Synuclein Transgenic Mice
por: Bachurin, Sergey O., et al.
Publicado: (2011)

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
por: Steele, John W., et al.
Publicado: (2012)

Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability
por: Weisová, P, et al.
Publicado: (2013)

Traditional used Plants against Cognitive Decline and Alzheimer Disease
por: Eckert, Gunter Peter
Publicado: (2010)

Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease
por: Esselun, Carsten, et al.
Publicado: (2021)

Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease
por: Babylon, Lukas, et al.
Publicado: (2021)

Pharmacology: The Pharmacodynamics of Nutrients and Nutrient Interactions in Biological Functions
por: Mohajeri, M. Hasan, et al.
Publicado: (2015)

Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients
por: Eckert, Gunter P., et al.
Publicado: (2009)

Dimebon Does Not Ameliorate Pathological Changes Caused by Expression of Truncated (1–120) Human Alpha-Synuclein in Dopaminergic Neurons of Transgenic Mice
por: Shelkovnikova, Tatyana A., et al.
Publicado: (2011)

Combination of Secondary Plant Metabolites and Micronutrients Improves Mitochondrial Function in a Cell Model of Early Alzheimer’s Disease
por: Babylon, Lukas, et al.
Publicado: (2023)

Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells
por: Dieter, Fabian, et al.
Publicado: (2022)

Rice bran derivatives alleviate microglia activation: possible involvement of MAPK pathway
por: Bhatia, Harsharan S., et al.
Publicado: (2016)

Investigating hesperetin nanocrystals with tailor-made sizes for the prevention and treatment of Alzheimer’s disease
por: Stahr, Pascal-L., et al.
Publicado: (2021)

Look who is calling: a comparison of genotype calling algorithms
por: Vens, Maren, et al.
Publicado: (2009)

Age-Dependent Alterations of Cognition, Mitochondrial Function, and Beta-Amyloid Deposition in a Murine Model of Alzheimer’s Disease—A Longitudinal Study
por: Reutzel, Martina, et al.
Publicado: (2022)

Effects of Combining Biofactors on Bioenergetic Parameters, Aβ Levels and Survival in Alzheimer Model Organisms
por: Babylon, Lukas, et al.
Publicado: (2022)

Effects of 7,8-Dihydroxyflavone on Lipid Isoprenoid and Rho Protein Levels in Brains of Aged C57BL/6 Mice
por: Ötzkan, Sarah, et al.
Publicado: (2020)

Identification of over 200-fold more hairpin ribozymes than previously known in diverse circular RNAs
por: Weinberg, Christina E, et al.
Publicado: (2021)

Walnut Oil Reduces Aβ Levels and Increases Neurite Length in a Cellular Model of Early Alzheimer Disease
por: Esselun, Carsten, et al.
Publicado: (2022)

Pharmacology Research & Perspectives calls for pharmacology education papers
por: Martin, Jennifer, et al.
Publicado: (2021)

Alzheimer's - Looking beyond plaques
por: Griffin, W. Sue T.
Publicado: (2011)

Caenorhabditis elegans as a Model for the Effects of Phytochemicals on Mitochondria and Aging
por: Schmitt, Fabian, et al.
Publicado: (2022)

Indian way of psychotherapy: Looking at the possibilities
por: Mukhopadhyay, Anirban
Publicado: (2012)

Traumatic testicular torsion: A call to look beyond the obvious
por: Ogbetere, Friday Emeakpor
Publicado: (2021)

A critical look at the practice and culture of science with calls to action
por: Al-Abadleh, Hind A.
Publicado: (2023)

Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity
por: Eckert, Anne, et al.
Publicado: (2011)

Link between the unfolded protein response and dysregulation of mitochondrial bioenergetics in Alzheimer’s disease
por: Poirier, Yannik, et al.
Publicado: (2019)

Modes of Aβ toxicity in Alzheimer’s disease
por: Götz, Jürgen, et al.
Publicado: (2011)

Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
por: Grimm, Amandine, et al.
Publicado: (2012)

Looking back on a life of unacknowledged privilege and a call to action
por: Peifer, Mark
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1o9qfems34951s3gtqc0nbrbjp